Trinity Biotech plc received a non-compliance notice from Nasdaq on February 19, 2026, after failing to maintain the minimum market value of publicly held shares (MVPHS) required under listing standards. The company's MVPHS fell below the $15 million threshold mandated by Nasdaq Listing Rule 5450(b), triggering the regulatory notification.
The Irish diagnostics company has until August 18, 2026—a period of 180 calendar days—to restore compliance with the minimum MVPHS requirement or face potential delisting from the Nasdaq Global Select Market. During this compliance period, Trinity Biotech's American Depositary Shares (ADSs) will continue trading under the ticker symbol 'TRIB' without interruption.
Non-compliance notices are standard regulatory communications that provide listed companies with a defined timeframe to address deficiencies before facing more severe consequences. Trinity Biotech's management will need to implement measures to increase its publicly held share value to meet the exchange's requirements within the specified window.